PCM
RCKT icon

Prelude Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Prelude Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-47,247
Closed -$594K – 1490
2024
Q4 		$594K Buy
+47,247
New +$711K 0.05% 536
2024
Q1 		– Sell
-20,400
Closed -$611K – 1526
2023
Q4 		$611K Buy
+20,400
New +$450K 0.05% 434
2020
Q1 		– Sell
-184
Closed -$4K – 2081
2019
Q4 		$4K Buy
+184
New +$3.07K ﹤0.01% 1791
2019
Q3 		– Sell
-204
Closed -$3K – 2099
2019
Q2 		$3K Buy
204
+46
+29% +$803 ﹤0.01% 1553
2019
Q1 		$3K Buy
158
+3
+2% +$47 ﹤0.01% 1670
2018
Q4 		$2K Buy
+155
New +$2.57K ﹤0.01% 1690
2018
Q3 		– Sell
-8,133
Closed -$160K – 2057
2018
Q2 		$160K Buy
+8,133
New +$154K 0.01% 797

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return